__________________________________________________________________________________________
30/JUN/2014
Re: Local ID TH140101451 / TH201401004136 FU (2)
Thank you for reporting to us a serious adverse event related to Lilly product.
We would like to collect more information to better understanding the reported event.
Please respond to following questions regarding the adverse event – Death, involving a female patient, age 90 yrs, who was subscribed Forteo, reported the event to Lilly on 13/JAN/2014.
Please, try to contact the HCP and use the following questions:
1. What was the medical history of the patient?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
2. Did the patient receive any concomitant medication?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
3. When did the event of hyperkalemia start?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
4. Did the patient receive any corrective treatment due to the event?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
5. What was the cause of hyperkalemia?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
6. Did the patient have any risk factors for cardiac arrest (e.g. coronary artery disease, other heart disease)?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
7. Did the patient undergo any exam? If yes, please provide: name, date, results and normal range.
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
8. Was the patient hospitalized? What was the start date of the hospitalization?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
9. Was an autopsy performed? If available, please provide a copy from the document.
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
10. What was the relatedness opinion between the treatment and the events?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
Thanks
Yours sincerely,
ELI LILLY AND COMPANY
Sasithorn Suntharo
Pharmacovigilance Associate
HCP’s signature:
Date:
__________________________________________________________________________________
For Eli Lilly internal use only
Date of Confirmation of FU request sent to HCP:
Name and Designation: